Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Labopin

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|April 8, 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMTP Chevallier, M Labopin, A Nagler, et al.
Journal of Hematology & Oncology|January 21, 2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemiaSimona Piemontese, F Ciceri, M Labopin, et al.
Bone Marrow Transplantation|November 19, 2013
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and realityM Labopin, N-C Gorin, E Polge, et al.
Leukemia|February 1, 2012
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMTA Spyridonidis, M Labopin, C Schmid, et al.
Bone Marrow Transplantation|October 3, 2020
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMTJ Loke, M Labopin, C Craddock, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Bone Marrow Transplantation|May 1, 1997
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) StudyO Ringdén, M Labopin, E Gluckman, et al.
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Journal of Internal Medicine|April 24, 2012
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patientsO Ringdén, M Labopin, D W Beelen, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|April 8, 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMTP Chevallier, M Labopin, A Nagler, et al.
Journal of Hematology & Oncology|January 21, 2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemiaSimona Piemontese, F Ciceri, M Labopin, et al.
Bone Marrow Transplantation|November 19, 2013
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and realityM Labopin, N-C Gorin, E Polge, et al.
Leukemia|February 1, 2012
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMTA Spyridonidis, M Labopin, C Schmid, et al.
Bone Marrow Transplantation|October 3, 2020
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMTJ Loke, M Labopin, C Craddock, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Bone Marrow Transplantation|May 1, 1997
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) StudyO Ringdén, M Labopin, E Gluckman, et al.
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Journal of Internal Medicine|April 24, 2012
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patientsO Ringdén, M Labopin, D W Beelen, et al.
Pageof 13